Article
In vitro activities of telithromycin, linezolid, and quinupristin-dalfopristin against Streptococcus pneumoniae with macrolide resistance due to ribosomal mutations.
Antimicrobial agents and chemotherapy - 1 Aug 2004
Farrell David J, Morrissey Ian, Bakker Sarah, Buckridge Sylvie, Felmingham David
Abstract excerpt
To date, 86 of 7,746 macrolide-resistant Streptococcus pneumoniae isolates from 1999 to 2002 PROTEKT (Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin) surveillance studies were negative for methylase and efflux mechanisms. Mutations in 23S rRNA or the genes encoding riboprotein L4 or L22 were found in 77 of 86 isolates. Six isolates were resistant to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
